MENU
+Compare
KYKOY
Stock ticker: OTC
AS OF
Oct 14 closing price
Price
$17.65
Change
+$1.65 (+10.31%)
Capitalization
7.74B

KYKOY stock forecast, quote, news & analysis

Kyowa Kirin, formerly Kyowa Hakko Kirin, was formed in 2008 through the merger of Kyowa Hakko Kogyo and Kirin Pharma following the capital alliance between Kyowa Hakko Group and Kirin Group... Show more

KYKOY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for KYKOY with price predictions
Oct 17, 2025

KYKOY's Stochastic Oscillator is remaining in overbought zone for 2 days

Expect a price pull-back in the near future.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis
Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where KYKOY's RSI Oscillator exited the oversold zone, of 7 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on October 14, 2025. You may want to consider a long position or call options on KYKOY as a result. In of 10 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for KYKOY just turned positive on October 14, 2025. Looking at past instances where KYKOY's MACD turned positive, the stock continued to rise in of 9 cases over the following month. The odds of a continued upward trend are .

KYKOY moved above its 50-day moving average on October 14, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for KYKOY crossed bullishly above the 50-day moving average on October 15, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 3 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating for company is (best 1 - 100 worst), which means the company is slightly undervalued. The valuation of the company is based on a proprietary formula which takes into account a set of fundamentals and gives us an estimate of the price per share for the company. We then compare this estimate with the current price per share. As a result, this company is rated as undervalued in the industry. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.657) is normal, around the industry mean (9.785). P/E Ratio (36.265) is within average values for comparable stocks, (24.212). KYKOY's Projected Growth (PEG Ratio) (4.933) is slightly higher than the industry average of (2.012). Dividend Yield (0.022) settles around the average of (0.028) among similar stocks. P/S Ratio (2.833) is also within normal values, averaging (3.527).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. KYKOY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KYKOY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 77, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), AstraZeneca PLC (NASDAQ:AZN), Merck & Co (NYSE:MRK), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Pfizer (NYSE:PFE), Bristol-Myers Squibb Co (NYSE:BMY), Biogen (NASDAQ:BIIB).

Industry description

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

Market Cap

The average market capitalization across the Pharmaceuticals: Major Industry is 94.08B. The market cap for tickers in the group ranges from 72.83K to 719.7B. LLY holds the highest valuation in this group at 719.7B. The lowest valued company is CRXTQ at 72.83K.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Major Industry was 0%. For the same Industry, the average monthly price growth was 2%, and the average quarterly price growth was 19%. MIRA experienced the highest price growth at 29%, while CHJTF experienced the biggest fall at -18%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Major Industry was -16%. For the same stocks of the Industry, the average monthly volume growth was 3% and the average quarterly volume growth was -24%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 32
P/E Growth Rating: 65
Price Growth Rating: 51
SMR Rating: 62
Profit Risk Rating: 77
Seasonality Score: -1 (-100 ... +100)
View a ticker or compare two or three
KYKOY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
N/A
Address
1-9-2,Otemachi, Chiyoda-ku
Phone
+81 352057200
Employees
7242
Web
http://www.kyowa-kirin.com